Trial Profile
Phase 2 study of GRN-1201 with an immune checkpoint antibody.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 11 Jul 2017
Price :
$35
*
At a glance
- Drugs GRN 1201 (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 11 Jul 2017 New trial record